Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL628978 | 0.92 | STAT3 (0.32) | STAT3 | |
| SCHEMBL18059323 | 0.82 | — | — | |
| SCHEMBL14107833 | 0.81 | STAT3 (0.32) | STAT3 | |
| SCHEMBL14107813 | 0.80 | STAT3 (0.37) | STAT3 | |
| SCHEMBL10125544 | 0.79 | — | — | |
| SCHEMBL13089972 | 0.77 | STAT3 (0.31) | STAT3 | |
| SCHEMBL14107868 | 0.77 | STAT3 (0.31) | STAT3 | |
| SCHEMBL6655447 | 0.73 | PPM1D (0.33) | PPM1D | |
| SCHEMBL12397926 | 0.71 | PPM1D (0.31) | PPM1D | |
| SCHEMBL13090098 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120115824-A1 | Vitamin D Receptor Agonists and Uses Thereof | VIDASYM, LLC (US) | 2012-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120115824-A1 | Vitamin D Receptor Agonists and Uses Thereof | VDR, CYP2R1, CYP24A1 | STAT3 415/4885PPM1D 664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.